Second half a slight improvement on first half in terms of revenue and NPAT, so little impact from covid on results. Main impact seems to be on slowing in new sales, so suggesting similar NPAT this year. Higher dividend, but unfranked of course.I suspect they are being conservative on this year's NPAT forecast, but they are on a PE of 26.
- Forums
- ASX - By Stock
- BVS
- Ann: FY20 Results Announcement
BVS
bravura solutions limited.
Add to My Watchlist
0.90%
!
$2.24

Ann: FY20 Results Announcement, page-3
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$2.24 |
Change
0.020(0.90%) |
Mkt cap ! $1.004B |
Open | High | Low | Value | Volume |
$2.21 | $2.30 | $2.20 | $1.937M | 859.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 16253 | $2.22 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.26 | 6753 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3652 | 2.190 |
3 | 30000 | 2.180 |
2 | 18216 | 2.170 |
1 | 450 | 2.150 |
1 | 7000 | 2.140 |
Price($) | Vol. | No. |
---|---|---|
2.260 | 500 | 1 |
2.300 | 815 | 1 |
2.310 | 236 | 1 |
2.320 | 740 | 1 |
2.400 | 1580 | 2 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
BVS (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online